Italy Clinical Trial Biorepository & Archiving Solutions Market Size & Outlook
Italy clinical trial biorepository & archiving solutions market, 2018-2030 (US$M)
Related Markets
Italy clinical trial biorepository & archiving solutions market highlights
- The Italy clinical trial biorepository & archiving solutions market generated a revenue of USD 189.0 million in 2023 and is expected to reach USD 303.2 million by 2030.
- The Italy market is expected to grow at a CAGR of 7% from 2024 to 2030.
- In terms of segment, biorepository services was the largest revenue generating service in 2023.
- Biorepository Services is the most lucrative service segment registering the fastest growth during the forecast period.
Clinical trial biorepository & archiving solutions market data book summary
| Market revenue in 2023 | USD 189.0 million |
| Market revenue in 2030 | USD 303.2 million |
| Growth rate | 7% (CAGR from 2023 to 2030) |
| Largest segment | Biorepository services |
| Fastest growing segment | Biorepository Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biorepository Services, Archiving Solution Services |
| Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Other key industry trends
- In terms of revenue, Italy accounted for 4.7% of the global clinical trial biorepository & archiving solutions market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, France clinical trial biorepository & archiving solutions market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 477.6 million by 2030.
Biorepository services was the largest segment with a revenue share of 66.35% in 2024. Horizon Databook has segmented the Italy clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
In Italy, biobank is majorly a nonprofit organization, which has to be officially registered by the appropriate healthcare authority in member states. Biobanks must offer conservation & distribution of biological material and treatment as per the standards of quality. However, biobanks and clinical trial biorepository & archiving solutions are still in the developing stage in Italy.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Trial Biorepository & Archiving Solutions Market Scope
Clinical Trial Biorepository & Archiving Solutions Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Italy clinical trial biorepository & archiving solutions market size, by service, 2018-2030 (US$M)
Italy Clinical Trial Biorepository & Archiving Solutions Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
